ZA974893B - New benzimidazole derivatives with antihistaminic activity. - Google Patents

New benzimidazole derivatives with antihistaminic activity.

Info

Publication number
ZA974893B
ZA974893B ZA9704893A ZA974893A ZA974893B ZA 974893 B ZA974893 B ZA 974893B ZA 9704893 A ZA9704893 A ZA 9704893A ZA 974893 A ZA974893 A ZA 974893A ZA 974893 B ZA974893 B ZA 974893B
Authority
ZA
South Africa
Prior art keywords
benzimidazole derivatives
antihistaminic activity
new benzimidazole
new
antihistaminic
Prior art date
Application number
ZA9704893A
Other languages
English (en)
Inventor
Aurelio Orjales
Maravillas Bordell
Victor Rubio
Original Assignee
Espanola Prod Quimicos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Espanola Prod Quimicos filed Critical Espanola Prod Quimicos
Publication of ZA974893B publication Critical patent/ZA974893B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9704893A 1996-06-04 1997-06-03 New benzimidazole derivatives with antihistaminic activity. ZA974893B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (1)

Publication Number Publication Date
ZA974893B true ZA974893B (en) 1997-12-30

Family

ID=8295035

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704893A ZA974893B (en) 1996-06-04 1997-06-03 New benzimidazole derivatives with antihistaminic activity.

Country Status (27)

Country Link
US (1) US5877187A (instruction)
EP (1) EP0818454B1 (instruction)
JP (1) JP4218991B2 (instruction)
CN (1) CN1105716C (instruction)
AR (1) AR008386A1 (instruction)
AT (1) ATE264317T1 (instruction)
AU (1) AU725700B2 (instruction)
BR (1) BR9703276A (instruction)
CA (1) CA2206754C (instruction)
CZ (1) CZ289278B6 (instruction)
DE (2) DE69728608T2 (instruction)
DK (1) DK0818454T3 (instruction)
ES (1) ES2124167B1 (instruction)
FR (1) FR11C0023I2 (instruction)
HR (1) HRP970307B1 (instruction)
HU (1) HU227598B1 (instruction)
IN (1) IN186319B (instruction)
LU (1) LU91798I2 (instruction)
MX (1) MXPA97004127A (instruction)
NO (2) NO313195B1 (instruction)
PL (1) PL188908B1 (instruction)
PT (1) PT818454E (instruction)
RU (1) RU2182150C2 (instruction)
SI (1) SI0818454T1 (instruction)
TR (1) TR199700464A3 (instruction)
TW (1) TW438794B (instruction)
ZA (1) ZA974893B (instruction)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001679A1 (fr) 1998-07-01 2000-01-13 Takeda Chemical Industries, Ltd. Regulateurs du recepteur associe aux retinoides
CN1184208C (zh) 1998-11-27 2005-01-12 巴斯福股份公司 取代的苯并咪唑及其制备和用途
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
MXPA04010313A (es) 2002-04-19 2005-06-08 Faes Farma Sa Polimorfo del acido 4- [2-[4 -[1(2- etoxietil) -1h- bencimidazol -2-il]-1 -piperidinil] etil]- alfa, alfa- dimetil -bencenoacetico.
RU2288917C2 (ru) * 2002-04-19 2006-12-10 Фаэс Фарма, С.А. Полиморф 4-[2-[4-[1-(2-этоксиэтил)-1h-бензимидазол-2-ил]-1-пиперидинил]этил]-альфа, альфа-диметилбензолуксусной кислоты, способ его получения, фармацевтический препарат на его основе и его применение
AU2003245442B2 (en) * 2002-06-13 2009-02-05 Vertex Pharmaceuticals Incorporated 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US8367704B2 (en) * 2008-02-12 2013-02-05 Yuhan Corporation Process for preparation of 2-methyl-2′ phenylpropionic acid derivatives and novel intermediate compounds
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
JP6284616B2 (ja) * 2013-03-15 2018-02-28 ハーキュリーズ・インコーポレーテッドＨｅｒｃｕｌｅｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 沈着特性が改善されたパーソナルケア組成物を生成する組成物及び方法
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
CA2993134A1 (en) * 2015-07-24 2017-02-02 Urquima, S.A. Crystalline forms of bilastine and preparation methods thereof
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds
EP3170817A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-crystals of benzimidazole compounds
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
WO2017191651A1 (en) * 2016-05-05 2017-11-09 Msn Laboratories Private Limited, R & D Center Solid state forms of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid and process for preparation thereof
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
EP3453384B1 (en) 2017-09-07 2020-05-27 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine
ES2858573T3 (es) 2017-10-16 2021-09-30 Faes Farma Sa Composiciones acuosas que comprenden bilastina y mometasona
WO2019097091A1 (en) 2017-12-18 2019-05-23 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Pharmaceutical tablet composition comprising bilastine form 3 and a water-soluble filler
ES2835287T3 (es) 2017-12-18 2021-06-22 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica de comprimido que comprende la forma polimórfica 3 de bilastina y aluminometasilicato de magnesio
LT3740191T (lt) 2018-01-18 2021-08-10 Faes Farma, S.A. Oftalmologinės kompozicijos, apimančios bilastiną, beta-ciklodekstriną ir bent vieną gelinimo agentą
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
WO2022023463A1 (en) 2020-07-30 2022-02-03 Faes Farma, S.A. Decongestant drug delivery system
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
EP4247331B1 (en) 2020-11-18 2025-10-08 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound
CA3200779A1 (en) 2020-12-23 2022-06-30 Strusi ORAZIO LUCA A non-micronized bilastine composition
US20250228836A1 (en) 2022-02-17 2025-07-17 Faes Farma, S.A. Bilastine composition for once-daily parenteral administration
WO2024224308A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine free of cyclodextrins
WO2024224326A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
JPH05507469A (ja) * 1990-04-13 1993-10-28 スミスクライン・ビーチャム・コーポレイション 置換ベンズイミダゾール
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
DK0815860T3 (da) * 1992-08-03 2006-08-14 Sepracor Inc Terfenadincarboxylat og behandlingen af allergiske lidelser
EP2261208A1 (en) * 1993-06-25 2010-12-15 Aventisub II Inc. Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives

Also Published As

Publication number Publication date
NO313195B1 (no) 2002-08-26
AU725700B2 (en) 2000-10-19
CN1105716C (zh) 2003-04-16
JP4218991B2 (ja) 2009-02-04
RU2182150C2 (ru) 2002-05-10
JPH1059961A (ja) 1998-03-03
MXPA97004127A (es) 2005-07-25
EP0818454A1 (en) 1998-01-14
LU91798I2 (fr) 2011-05-23
HRP970307B1 (en) 2002-02-28
TR199700464A2 (xx) 1997-12-21
EP0818454B1 (en) 2004-04-14
NO2011008I2 (no) 2012-05-14
CZ289278B6 (cs) 2001-12-12
FR11C0023I1 (instruction) 2011-08-19
NO972525D0 (no) 1997-06-03
TW438794B (en) 2001-06-07
AR008386A1 (es) 2000-01-19
DK0818454T3 (da) 2004-07-12
US5877187A (en) 1999-03-02
CA2206754C (en) 2007-01-23
ES2124167B1 (es) 1999-09-16
AU2467297A (en) 1997-12-11
CA2206754A1 (en) 1997-12-04
SI0818454T1 (en) 2004-08-31
IN186319B (instruction) 2001-08-04
PL188908B1 (pl) 2005-05-31
FR11C0023I2 (fr) 2012-03-16
HUP9700997A1 (hu) 1999-09-28
NO2011008I1 (no) 2011-06-06
TR199700464A3 (tr) 1997-12-21
HRP970307A2 (en) 1998-04-30
ES2124167A1 (es) 1999-01-16
BR9703276A (pt) 2004-08-17
CZ172397A3 (en) 1997-12-17
DE69728608T2 (de) 2005-04-21
DE69728608D1 (de) 2004-05-19
HU9700997D0 (en) 1997-07-28
CN1176964A (zh) 1998-03-25
ATE264317T1 (de) 2004-04-15
NO972525L (no) 1997-12-05
PT818454E (pt) 2004-08-31
DE122011000006I1 (de) 2011-06-16
HU227598B1 (en) 2011-09-28
PL320358A1 (en) 1997-12-08

Similar Documents

Publication Publication Date Title
ZA974893B (en) New benzimidazole derivatives with antihistaminic activity.
ZA982853B (en) Nicotinamide derivatives.
IS5860A (is) 4,4-bíarýlpíperidín afleiður með ópíóíð viðtaka virkni
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
ZA979593B (en) Naphthyridine derivatives.
HRP980303B1 (en) Benzimidazole derivatives
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
ID26743A (id) Turunan 1,2,4,5-tetrahidro-benzo [d] azepin
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA978045B (en) New benzamidine derivatives.
IL133674A0 (en) Benzimidazole derivatives
IL127432A0 (en) Substituted benzimidazole derivatives
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
FI970469L (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
ZA977833B (en) N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylate inhibitory activity.
ZA979781B (en) Piperidine derivatives.
ZA982436B (en) Thiazolimine derivatives.
ZA977791B (en) GLP-1 derivatives.
ZA200006632B (en) Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
ZA9710062B (en) Heterocyclic derivatives.
ZA964692B (en) Benzimidazole derivatives.
ZA981224B (en) Benzimidazole derivatives.
ZA984948B (en) Benzimidazole derivatives.